Lisinopril Tablet
Product Images NDC 42708-096

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 42708-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708 096 30

42708 096 30
Label for Lisinopril Tablets USP, 40 mg, oral tablets in a bottle containing 30 tablets. The label states it is a sample not for sale and instructs to see the package insert for dosage. Distributed by QPharma, Inc., Cedar Knolls, NJ. Storage instructions specify controlled room temperature. The label includes space for directions and indicates Rx only.*
FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)
Chemical structure diagram of the active ingredient Lisinopril, showing its molecular arrangement including amine, carboxyl, and cyclic components with hydrate (2H2O) indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.